Please browse these pages to find out more about successful spin-out companies and licensing deals negotiated by Warwick Ventures on behalf of the University of Warwick.
4D Medicine Ltd formed to take new biomaterials to market
4D Medicine has developed a patented range of novel polymeric 3-D printing resin-inks that can be printed into solid 3D scaffold implants to help patients recover from major medical procedures.
Stoli Catalysts wins RSC and MICRA grants
Work in the new laboratory starts, supported by grants and a Royal Society of Chemistry graduate internship award.
Rapid diagnostic test for COVID-19
University of Warwick researchers are developing a new test for Coronavirus which potentially offers significant benefits because it delivers a very rapid result and requires no specialist lab equipment or training to complete. The result is that people could determine very quickly whether they have a current infection and take appropriate action.
Care Companion demonstrates vital role of online resources in carers’ wellbeing during lockdown
In response to a marked increase in homelessness, in parallel with abusiveness and antisocial behaviour towards the homeless on the rise, two exciting resources to raise awareness of the experiences and issues faced by the homeless have been created.
Sarissa Biomedical develops rapid test for stroke
Sarissa Biomedical has developed the world’s first blood test for stroke. It is a simple finger-prick blood test delivering greater diagnostic accuracy within 3 minutes, helping rapid intervention to prevent less severe disabilities and shorter hospital stays.
Medherant partners with Cycle Pharmaceuticals for pipeline expansion
Cycle will utilise Medherant’s proprietary TEPI Patch® transdermal delivery technology to develop formulations that will address patients’ unmet needs such as dysphagia and dyskinesia, further expanding its pipeline.
AWPN Online Education Toolkit
The African Women Playwrights Network is a pan-African virtual network of writers and writing by disenfranchised women playwrights. With the support of Warwick Ventures, AWPN created and launched an online educational toolkit.
Rapid discovery of natural product medicines and agrochemicals
Erebagen has developed a platform that enables it to engineer soil bacteria to produce new bioactive natural products with hit-rates 20x-better than synthetic chemicals currently being used in industrial screens.